Search

Search Constraints

You searched for: Author/Creator Doležil, David

Search Results

2. Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study. (May 2020)

4. Long‐term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysis. Issue 5 (20th May 2022)

5. Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial. Issue 6 (June 2017)